Lynparza 150 MG tablet UU 120S
Ended Awarded Last action
- Contract number
- SPE2DR26FT5WT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,822
Award facts
- Contract value 100% obligated
- $36,822.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 28, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $36,822.27 to AmerisourceBergen Drug Corp for the supply of LYNPARZA 150 mg tablets (120-count unit). The contract is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. Performance will be fulfilled at the contractor's Conshohocken, Pennsylvania location, with an ultimate completion date of February 19, 2026. This delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to military healthcare systems globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor that supplies critical medications to federal military and veteran healthcare systems through the DLA Medical Supply Chain. LYNPARZA (olaparib) is an oncology medication used to treat certain cancers, reflecting the company's role in delivering specialized pharmaceutical products across multiple therapeutic domains. The DLA Troop Support Medical contract vehicle enables efficient procurement of essential medications and medical commodities required by military treatment facilities and Defense Health Agency programs, with this particular order representing a routine replenishment of cancer treatment medications to support military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FT5WT?
SPE2DR26FT5WT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FT5WT worth?
The government has obligated $36,822 on SPE2DR26FT5WT.
Is contract SPE2DR26FT5WT an order under another contract?
Yes. SPE2DR26FT5WT is a delivery order under SPE2DR25D3201, an indefinite delivery contract.
Was contract SPE2DR26FT5WT competed?
The extent of competition for SPE2DR26FT5WT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award